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Abstract
Background: We previously demonstrated that extracapsular invasion (ECI) at a metastatic sentinel node was
significantly associated with the presence of positive non-sentinel nodes in patients with breast cancer. However,
the mechanism of metastatic spreading of tumor cells to distant lymph nodes in patients with colorectal
carcinoma is not fully understood. In this study, we investigated the factors that may determine the likelihood of
additional regional lymph node metastasis when metastasis is found in nodes at the N1 site in colorectal cancer,
especially focusing on the presence of ECI.
Methods: Two hundred and twenty-eight consecutive patients who underwent colorectal resection were
identified for inclusion in this study, of which 37 (16.2%) had positive lymph nodes at the N1 site. Six of these
37 cases had additional metastasis in N2 site lymph nodes. We reviewed the clinicopathological features of these
cases and performed statistical analysis of the data.
Results: In the univariate analysis ECI at the N1 site was the only factor significantly associated with the presence
of cancer cells in the N2 site. Other factors, including number of positive lymph nodes, lymphovascular invasion of
the primary tumor, tumor size and tumor depth of invasion, were not associated with metastatic involvement at
the N2 site.
Conclusions: Our results suggest that the presence of ECI at metastatic lymph nodes at the N1 site is correlated
with further metastasis at the N2 site. These findings imply the possibility that ECI might indicate the ability of
colorectal tumor cells to disseminate to distant lymph nodes.
Background
Lymph node status is one of the most important prog-
nostic factors for colorectal carcinoma. Tumor cells
invade the lymphatic vessels, which enables tumor cells
to penetrate into the lymphatic system. Both experimen-
tal tumor models and human clinicopathologic data
indicate that growth of lymphatic vessels near solid
tumors is often associated with lymph node metastasis
[1,2]. However, little is known about the mechanism or
process of metastatic spreading of tumor cells to distant
regional lymph nodes in patients with colorectal carci-
noma with positive lymph nodes.
We previously reported that the presence of an extra-
capsular invasion (ECI) at sentinel lymph nodes was a
strong predictor of residual axillary disease, or non-sen-
tinel lymph node metastasis in breast cancer [3,4], and
the identification of the ECI of the metastatic lymph
nodes has been reported as a prognostic factor in
patients with colorectal cancer [5-7]. Thus, the purpose
of this study was to investigate the correlation between
the presence of ECI of positive lymph nodes at the N1
site and nodal metastasis at the N2 site in cases with
resectable colorectal cancer.
Methods
Two hundred and twenty-eight consecutive patients who
underwent colorectal resection in the Department of
General Surgical Science, Graduate School of Medicine,
Gunma University, from January 2007 to December
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any medium, provided the original work is properly cited.2009 were identified for inclusion in this study. Patients
with recurrent cases (2 cases), neo-adjuvant chemother-
apy and radiation (33 cases), skipping lymph node
metastases (9 cases) or incomplete clinical information
were excluded. Of these eligible cases, 37 (16.2%) had
positive lymph nodes at n1 (nodal metastases at the N1
site) and were analyzed in this study. The regional
lymph nodes were classified according to criteria of the
Japanese Research Society for Cancer of the Colon and
Rectum: pericolic lymph nodes that lie along the mar-
ginal arteries (N1 site); and central intermediate lymph
nodes that lie along the ileocolic, right colic, middle
colic, left colic, sigmoid, and inferior mesenteric arteries
from the origin of the last sigmoid artery to the origin
of the left colic artery (N2 site) [8,9]. Informed consent
for study participation was obtained from all patients.
Primary tumor size, tumor depth of invasion, age, sex,
histological type, lymphovascular invasion at the primary
tumor site, number of metastatic lymph nodes, extra-
capsular invasion (ECI) at positive lymph nodes and
serum tumor marker (carcinoembryonic antigen, CEA)
were tested as possible predictors of lymph node metas-
tases at the N2 site. ECI was defined as extra capsular
growth of tumor cells, invasion of perinodal fat or extra-
nodal location of tumor cells (Figure 1). All resected
lymph node were bisected in largest dimension. All
sections were paraffin-embedded and stained with
hematoxylin and eosin. Fisher’s exact test and Student’s
t-test were used to compare metastatic and unaffected
N2 site lymph nodes groups. Differences were consid-
ered to be significant when P <0 . 0 5 .T h em u l t i v a r i a t e
analysis was conducted using a regression model. To
test the independence of the factors, the variables in the
univariate analyses were entered into a multiple regres-
sion analysis with a likelihood of P < 0.05.
Results
The 37 cases with metastatic lymph nodes at the N1 site
were divided into two groups based on the presence or
absence of metastasis at N2 site lymph nodes. Among
37 cases with positive lymph nodes at the N1 site, 6
(16.2%) had metastatic lymph nodes at the N2 site.
Table 1 shows the patients and tumor characteristics.
The mean age was 65.6 ± 14.7 years and the mean pri-
mary tumor size was 41.6 ± 18.2 mm. Table 1 also sum-
marizes the results of the univariate analysis conducted
to determine the relationship between the clinicopatho-
logic variables and the presence of N2 site metastasis.
Age, histological type, number of positive lymph nodes,
lymphovascular invasion of the primary tumor, tumor
size, tumor depth of invasion and serum CEA were not
predictors of metastatic involvement at the N2 site. In
the univariate analysis ECI at the N1 site was the only
factor significantly associated with the presence of
cancer cells in the N2 site (P = 0.005). Multivariate sub-
group analysis of the association between these factors
and recurrent disease showed that only the presence of
ECI was independently associated with recurrent disease
(RR = 2.30, 95%; CI 1.25-4.22; P = 0.015). In the group
negative for metastasis at the N2 site, there were
a.
b.
c.
Figure 1 Histological examples of absence or presence of
extracapsular invasion (ECI) at metastatic lymph node. (a,b)
Case with present of ECI at metastatic lymph nodes; the tumor cells
invade through the capsule of the lymph node. (c) Case with
absent of ECI at metastatic lymph node; lymph node was contained
metastatic foci, however, tumor cells did not invade the capsule of
the lymph node.
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nodes was 3.89 ± 2.88 in those patients. One of the 9
cases with ECI without N2 metastasis had mucinous
adenocarinoma and one of the 9 cases had diffuse
matastasis at the N2 site. On the other hand, 1 of 6
cases with ECI and N2 metastasis had diffuse metastasis
at the N2 site. There were no significant difference
between the cases with ECI and N2 metastasis and the
cases with ECI and without N2 metastasis on clinico-
pathological findings. However, among 9 cases with ECI
and without N2 metastasis, 1 (11.1%) had disease recur-
rence and among 6 cases with ECI and N2 metastasis, 4
(66.7%) had recurrence.
Discussion
Lymph node metastasis is an important prognostic fac-
tor in patients with colorectal cancer, and many studies
have indicated that the location and number of meta-
static nodes affect prognosis [5,10-12]. Many studies
have described the risk factors of lymph node metas-
tases [1,2,13], but information regarding the mechanism
or process of the metastatic spread of tumor cells to dis-
tant regional lymph nodes in patients with colorectal
carcinoma is sparse at present. The key observations
made in this study can be summarized as follows: In
our cases with resected colorectal cancer with metastatic
lymph nodes, the presence of ECI at positive lymph
nodes at the N1 site was significantly associated with
lymph node metastasis at the N2 site. This finding sug-
g e s t st h a tE C Im a yb eak e yp r o c e s sf o l l o w i n gd i s t a n t
lymph node metastasis.
Previous studies have demonstrated and confirmed
that the presence of ECI at metastatic lymph nodes is
significantly related to prognosis in not only colorectal
carcinoma but also in various other types of carcinoma
[4-7,14-17]. The ability of metastatic nodes to recruit
degradation factors that permit cancer cells to break
through the lymph node capsule is indicative of a very
aggressive cancer. These studies imply that ECI is a bio-
logic marker of aggressive nodal disease. We previously
demonstrated that ECI at metastatic sentinel nodes in
breast cancer was strongly associated with non-sentinel
nodes metastasis [3]. These findings essentially support
our findings; the presence of ECI of positive lymph
nodes is significantly related to the nodal spread of the
tumor cells in colorectal cancer patients. Tumor cells
invade the lymphatic vessels, which enables the tumor
cells to penetrate into the lymphatic system. Further-
more, in the group negative for metastasis at the N2 site
there were 9 patients with ECI (Table 1), and the pre-
sence of ECI may be a clear sign of more aggressive dis-
ease, as those 9 patients had a greater total number of
positive lymph nodes than did the patients without ECI
(P < 0.05).
It is clear that the successful clinical application of
sentinel lymph node biopsy used in cases of breast can-
cer and melanoma cannot simply be transferred into
colorectal cancer treatment [18,19]. Sentinel lymph node
biopsy in cases with colorectal cancer is a controversial
issue, and we have sometimes experienced cases of col-
orectal cancer with skipping lymph node metastasis, in
which distant nodes were positive but those closer to
the tumor were negative. Skipping nodal metastases in
colorectal carcinoma suggested the possibility of a
bypass flow that has not been generally recognized [20].
In our series, skipping nodal metastasis was observed in
9 cases among the 46 cases with positive lymph nodes.
Therefore, the presence of ECI at a positive lymph node
might explain in part the mechanism or process to dis-
seminate to distant regional lymph nodes, and there
thought to be other mechanism, including skipping
nodal metastasis.
This study has potential limitations. The major limita-
tion of our study is that we used retrospective methods
of data collection. In addition, the number of cases in
our study was relatively small. However, the clinical
implications of this data are very important, and these
findings serve to emphasize that ECI at metastatic
lymph nodes is one of the processes or mechanisms of
distant lymph node dissemination and is a biologic mar-
ker of aggressive nodal disease. Additional research is
needed to explore other patterns or mechanisms of
lymph node spreading.
Conclusions
In conclusion, we have demonstrated that ECI at meta-
static lymph nodes at the N1 site is related distant
regional lymph node metastasis at the N2 site in color-
ectal cancer, which might represent the ability or pro-
cess of colorectal tumor cells to disseminate to distant
Table 1 Patients characteristics and clinicopathologic
features associated with further lymph node metastases
at the N2 site
The N2 site metastasis Positive Negative
Patients (n) 6 31 P value
Age (y ± SD) 71.5 ± 14.9 64.5 ± 14.4 0.301
Gender (M/F, n) 2/4 22/9 0.193
Location (Colon/Rectum, n) 5/1 21/10 0.782
Histrogical type (tub1-2/muc, n) 5/1 30/1 0.729
Tumor size (mm) 49.5 ± 14.1 40.0 ± 18.5 0.256
pT category (T1,2/T3,4, n) 0/6 7/24 0.470
Number of positive LNs (n) 3.5 ± 1.0 2.2 ± 2.0 0.149
ECI (n) 6 9 0.005
Lymphovascular invasion (n) 6 30 0.353
CEA (3.0<, n) 2 10 0.671
LN, lymph node; ECI, extracapsular invasion.
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trials or experimental data are warranted to evaluate
this relationship between ECI and spreading of lymph
node metastasis.
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